Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years

OBJECTIVES: Brain acetylcholine is decreased even in patients with cognitively preserved Parkinson’s disease (PD). We investigated whether early and long-term use of donepezil prevents psychosis in non-demented PD patients. METHODS: A double-blinded, placebo-controlled trial was conducted. A total o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawada, Hideyuki, Oeda, Tomoko, Kohsaka, Masayuki, Umemura, Atsushi, Tomita, Satoshi, Park, Kwiyoung, Mizoguchi, Kouichi, Matsuo, Hidenori, Hasegawa, Kazuko, Fujimura, Harutoshi, Sugiyama, Hiroshi, Nakamura, Michikazu, Kikuchi, Seishi, Yamamoto, Kenji, Fukuda, Toshiaki, Ito, Suminobu, Goto, Masashi, Kiyohara, Kosuke, Kawamura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Neuropsychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288700/
https://www.ncbi.nlm.nih.gov/pubmed/30076270
http://dx.doi.org/10.1136/jnnp-2018-318107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288700/
https://www.ncbi.nlm.nih.gov/pubmed/30076270
http://dx.doi.org/10.1136/jnnp-2018-318107

Ejemplares similares